DSIP — Delta Sleep-Inducing Peptide — is a naturally occurring nonapeptide first isolated from cerebral venous blood, named for its association with the slow, delta-wave activity of deep sleep. It remains one of the more intriguing and still-debated endogenous signaling peptides.
Mechanism under investigation
Research connects DSIP to the regulation of sleep architecture, modulation of stress hormones (ACTH and cortisol), and possible roles in pain and thermoregulation. Its precise receptor targets are still being worked out, which is part of what makes it an active research subject.
Research applications
- Sleep regulation and circadian models.
- Stress-hormone and HPA-axis signaling.
- Chronic-pain and withdrawal models.
Clinical outlook
DSIP has a genuine, if early, human-research history: studies in the 1980s and 1990s explored it in sleep disturbance, chronic pain, and stress. As neuroscience renews its interest in the body’s own sleep-regulating peptides, DSIP is being revisited — and researchers are asking whether a naturally occurring sleep signal could inform a new generation of approaches to sleep and stress. Modern registered trials are still limited, making it a compelling target for translational work.
